文献速递妇科

术前口服与静脉对乙酰氨基酚在机器人辅助腹腔镜子宫切除术后镇痛中的随机对照试验

Preemptive Oral Compared With Intravenous Acetaminophen for Postoperative Pain After Robotic-Assisted Laparoscopic Hysterectomy: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2019-01-01

这项双盲随机试验纳入因良性指征行机器人辅助腹腔镜子宫切除术的女性,比较术前口服对乙酰氨基酚1 g与术前静脉对乙酰氨基酚1 g的术后疼痛。结果显示术后2小时及4小时、24小时两组平均疼痛评分均无差异,口服组与静脉组的恶心发生率、恢复室吗啡当量用量及请求镇痛时间亦无差异。作者认为,鉴于口服给药方便且成本更低,本研究支持将口服途径纳入微创妇科手术的加速康复外科方案。

要点

  • 术后2小时口服组与静脉组平均疼痛评分分别为35 mm与36 mm(P=.86),无差异。
  • 术后4小时两组疼痛评分为36 mm与37 mm(P=.96),24小时为35 mm与36 mm(P=.79)。
  • 口服组38%与静脉组19%发生恶心(P=.12),恢复室吗啡当量用量9.7 vs 9.5(P=.9)。

核心结论

  • 术前口服与静脉对乙酰氨基酚在机器人辅助腹腔镜子宫切除术后2小时疼痛无差异;鉴于口服给药方便且成本更低,本研究支持将口服途径纳入微创妇科手术的加速康复外科方案。

研究设计与样本

  • 双盲随机对照试验,纳入因良性指征行机器人辅助腹腔镜子宫切除术的女性,2016年4月至2017年8月共入组77例,最终分析纳入75例。
  • 样本量74例(每组37例)可在80%把握度下、单侧双样本t检验、α=0.025、非劣效界值10 mm条件下检验非劣效性。

主要发现

  • 术后2小时口服组与静脉组平均疼痛评分分别为35 mm与36 mm(P=.86),4小时分别为36 mm与37 mm(P=.96),24小时分别为35 mm与36 mm(P=.79)。
  • 口服组38%与静脉组19%的参与者发生恶心(P=.12)。
  • 口服组恢复室吗啡当量用量为9.7,静脉组为9.5(P=.9);口服组平均45分钟请求镇痛,静脉组平均43分钟(P=.79)。

关键数值与推荐

  • 主要结局为术后2小时两组间疼痛评分差异;非劣效界值为10 mm。
  • 术后2小时疼痛评分口服组35 mm vs 静脉组36 mm(P=.86),未显示差异。

临床怎么用

  • 作者认为,鉴于口服给药方便且成本更低,本研究支持将口服途径作为微创妇科手术加速康复外科方案的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare pain after robotic-assisted laparoscopic hysterectomy when giving preoperative oral compared with intravenous acetaminophen. METHODS: This double-blind randomized trial included women undergoing robotic-assisted laparoscopic hysterectomy for benign indications. Participants received either acetaminophen 1 g orally then normal saline 100 mL intravenously before surgery, or a placebo orally then acetaminophen 1 g intravenously. The primary outcome measured was difference in pain between the groups 2 hours postoperatively. A sample size of 74 participants (37/group) was needed to achieve 80% power to detect noninferiority using a one-sided, two-sample t-test with an alpha of 0.025 and a noninferiority margin of 10 mm. RESULTS: From April 2016 through August 2017, 77 patients were enrolled, with 75 participants included in the final analysis. Characteristics were similar between groups. No difference in average pain score was noted 2 hours after surgery, nor at any of the measured time points. Average scores for the oral and intravenous group, respectively, at 2 hours were 35 and 36 mm (P=.86), at 4 hours 36 and 37 mm (P=.96), and at 24 hours 35 and 36 mm (P=.79). Thirty-eight percent of participants in the oral group and 19% of participants in the intravenous group experienced nausea (P=.12). The oral group used 9.7 morphine equivalents in the recovery room, and the intravenous group used 9.5 morphine equivalents (P=.9). The oral group requested analgesia in 45 minutes on average, and the intravenous group requested analgesia in 43 minutes (P=.79). CONCLUSION: No difference in pain was observed 2 hours postoperatively when comparing preoperative administration of oral compared with intravenous acetaminophen. Given the ease of administration and lower cost of oral dosing, this study supports the oral route as part of the enhanced recovery after surgery protocol for minimally invasive gynecologic surgery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03391284.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lombardi TM, Kahn BS, Tsai LJ, et al. Preemptive Oral Compared With Intravenous Acetaminophen for Postoperative Pain After Robotic-Assisted Laparoscopic Hysterectomy: A Randomized Controlled Trial. Obstet Gynecol. 2019. PMID: 31764741. doi:10.1097/AOG.0000000000003578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。